Christodoulopoulos G - Search Results

1

Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair.

Panasci L, Paiement JP, Christodoulopoulos G, Belenkov A, Malapetsa A, Aloyz R. Panasci L, et al. Among authors: christodoulopoulos g. Clin Cancer Res. 2001 Mar;7(3):454-61. Clin Cancer Res. 2001. PMID: 11297233 Review.

2

Homologous recombinational repair vis-à-vis chlorambucil resistance in chronic lymphocytic leukemia.

Bello VE, Aloyz RS, Christodoulopoulos G, Panasci LC. Bello VE, et al. Among authors: christodoulopoulos g. Biochem Pharmacol. 2002 May 1;63(9):1585-8. doi: 10.1016/s0006-2952(02)00954-1. Biochem Pharmacol. 2002. PMID: 12007561

3

Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.

Bramson J, McQuillan A, Aubin R, Alaoui-Jamali M, Batist G, Christodoulopoulos G, Panasci LC. Bramson J, et al. Among authors: christodoulopoulos g. Mutat Res. 1995 May;336(3):269-78. doi: 10.1016/0921-8777(94)00063-c. Mutat Res. 1995. PMID: 7739615

4

Relationship between nitrogen mustard drug resistance in B-cell chronic lymphocytic leukemia (B-CLL) and protein expression of Bcl-2, Bax, Bcl-X and p53.

Christodoulopoulos G, Fotouhi N, Krajewski S, Reed JC, Alaoui-Jamali M, Panasci L. Christodoulopoulos G, et al. Cancer Lett. 1997 Dec 16;121(1):59-67. doi: 10.1016/s0304-3835(97)00336-4. Cancer Lett. 1997. PMID: 9459175

5

Potentiation of chlorambucil cytotoxicity in B-cell chronic lymphocytic leukemia by inhibition of DNA-dependent protein kinase activity using wortmannin.

Christodoulopoulos G, Muller C, Salles B, Kazmi R, Panasci L. Christodoulopoulos G, et al. Cancer Res. 1998 May 1;58(9):1789-92. Cancer Res. 1998. PMID: 9581813

6

Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemia.

Christodoulopoulos G, Malapetsa A, Schipper H, Golub E, Radding C, Panasci LC. Christodoulopoulos G, et al. Clin Cancer Res. 1999 Aug;5(8):2178-84. Clin Cancer Res. 1999. PMID: 10473103

7

In vitro evidence for homologous recombinational repair in resistance to melphalan.

Wang ZM, Chen ZP, Xu ZY, Christodoulopoulos G, Bello V, Mohr G, Aloyz R, Panasci LC. Wang ZM, et al. Among authors: christodoulopoulos g. J Natl Cancer Inst. 2001 Oct 3;93(19):1473-8. doi: 10.1093/jnci/93.19.1473. J Natl Cancer Inst. 2001. PMID: 11584063

8

DNA-Dependent protein kinase activity correlates with clinical and in vitro sensitivity of chronic lymphocytic leukemia lymphocytes to nitrogen mustards.

Muller C, Christodoulopoulos G, Salles B, Panasci L. Muller C, et al. Among authors: christodoulopoulos g. Blood. 1998 Oct 1;92(7):2213-9. Blood. 1998. PMID: 9746757 Free article.

9

Re: M. D. Dabholkar et al., Malignant and nonmalignant brain tissues differ in their messenger RNA expression patterns for ERCC1 and ERCC2. Cancer Res., 55: 1261-1266, 1995.

Panasci L, McQuillan A, Malapetsa A, Christodoulopoulos GR. Panasci L, et al. Among authors: christodoulopoulos gr. Cancer Res. 1995 Sep 1;55(17):3933-4. Cancer Res. 1995. PMID: 7641213 No abstract available.

10

In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines.

Avramis IA, Christodoulopoulos G, Suzuki A, Laug WE, Gonzalez-Gomez I, McNamara G, Sausville EA, Avramis VI. Avramis IA, et al. Among authors: christodoulopoulos g. Cancer Chemother Pharmacol. 2002 Dec;50(6):479-89. doi: 10.1007/s00280-002-0507-6. Epub 2002 Oct 17. Cancer Chemother Pharmacol. 2002. PMID: 12451475

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters